Title: Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
133073-73-1
59-05-2
136672-64-5
15475-56-6
34378-65-9
51865-79-3
1207995-62-7 | N-Nitroso-N,N-di(3,5,5-triMethylhexyl)aMine | AA008WCN | MFCD18379571
103876-98-8 | 4-Hydroxy Omeprazole Sulfide | AA008X5M | MFCD18379486
108847-96-7 | 5-Bromo-6-chloroindolyl 1,3-diacetate | AA008XHW | MFCD06797509
12062-24-7 | CUPRIC FLUOROSILICATE | AA008XXR | MFCD00049446
1027330-97-7 | A-943931 | AA008Y6S | MFCD25371543
1187582-53-1 | (1-Methylpiperidin-4-yl)methanamine dihydrochloride | AA008YZ0 | MFCD11035762
1072845-47-6 | (S)-Fmoc-2-amino-2-methyl-succinic acid-4-tert-butyl ester | AA008Z6E | MFCD12031692
1060805-97-1 | 6-bromo-2-methylpyridine-3-carboxylic acid | AA008ZRQ | MFCD13188658
1133115-78-2 | 5-Bromo-8-fluoroquinoline | AA0090D9 | MFCD11855895
1192548-05-2 | 2-(3-Fluoro-2-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | AA009098 | MFCD16996330